IND Faculty Gunaydin and Kampmann Named Chan Zuckerberg Biohub Investigators
|Drs. Martin Kampmann and Lisa Gunaydin, both Assistant Professors in the IND, celebrate being named Biohub investigators|
IND faculty Dr. Lisa Gunaydin and Dr. Martin Kampmann were named Chan Zuckerberg Biohub Investigators. They are part of the first cohort of 47 scientists from UCSF, Stanford, and Berkeley to join the Biohub.
The Biohub is a nonprofit research organization with the goal to develop new technologies that transform biomedical research. It is funded by a philanthropic investment of $600 million by Facebook founder Mark Zuckerberg and pediatrician Priscilla Chan.
The Biohub is located directly adjacent to the UCSF Mission Bay campus, less than a 5-minute walk from the IND. Dr. Gunaydin’s lab will collaborate with the Biohub to identify cellular and circuit mechanisms underlying behavioral symptoms of neuropsychiatric disease with the goal of identifying novel therapeutic interventions to restore normal behavior. Dr. Kampmann and members of his group will collaborate with other Biohub investigators to develop new technologies to reveal cellular mechanisms of neurodegenerative diseases and to uncover new potential therapeutic strategies.